Evidence map›Paper›PMID 42034905›Full record

ArticleNPJ systems biology and applications2026

Context-aware multi-property antibody predictor: a novel framework integrating text and protein language models.

Luca Giancardo, Melih Yilmaz, Edward Lee, Ke Ren, Yue Zhao, Gordon Trang, Kemal Sonmez, Lan Guo, Nina Cheng

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luca GiancardoLife Sciences, Amazon Web Services, Seattle, WA, USA. lugianca@amazon.com.
Melih YilmazLife Sciences, Amazon Web Services, Seattle, WA, USA.
Edward LeeLife Sciences, Amazon Web Services, Seattle, WA, USA.
Ke RenLife Sciences, Amazon Web Services, Seattle, WA, USA.
Yue ZhaoLife Sciences, Amazon Web Services, Seattle, WA, USA.
Gordon TrangLife Sciences, Amazon Web Services, Seattle, WA, USA.
Kemal SonmezLife Sciences, Amazon Web Services, Seattle, WA, USA.
Lan GuoLife Sciences, Amazon Web Services, Seattle, WA, USA.
Nina ChengLife Sciences, Amazon Web Services, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in Machine Learning have transformed antibody development through in silico models, accelerating therapeutic candidate identification. However, challenges persist: rapid adaptation of property predictors to laboratory-specific assays with incomplete datasets; batch effects introducing systematic bias; assay costs necessitating efficient unseen property prediction. We introduce a novel multimodal architecture featuring specialized tokenization and embedding projection that integrates text and protein language models (pLM) and a learning strategy to enable context-conditioned multi-property prediction without learning shortcuts. Our framework enables prompting without dictionary merging across modalities, creating a compact model capable of context-conditioned learning for multi-property prediction. The orchestrating model avoids pLM-to-text projection while enabling inference-time adaptation without retraining. Using 876,898 antibody heavy chain sequences with batch effect simulation, our architecture achieved Spearman's ρ > 0.8 across multiple developability properties, significantly outperforming fine-tuned multimodal LLMs and showed the ability to leverage correlation between properties for prediction. This approach has the potential to address critical antibody development challenges.

Indexed as

AntibodiesComputational BiologyAlgorithmsComputer SimulationHumansLarge Language ModelsMachine LearningPrediction AlgorithmsPredictive Learning ModelsProteinsAntibodiesProteins

Identifiers

PMID42034905
PMCPMC13324834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.